| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 4,600 | 10,532 | 12,845 | 12,780 | | Cost of Revenue | 3,893 | 7,520 | 7,479 | 6,539 | | | Gross Profit | 707 | 3,012 | 5,366 | 6,241 | | | Operating Expenses | | Research Development | 1,861 | 1,926 | 2,245 | 2,231 | | Selling General and Administrative | 5,309 | 8,031 | 9,881 | 8,253 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 42 | 43 | 42 | 72 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,505) | (6,988) | (6,802) | (4,315) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 178 | 158 | | Earnings Before Interest And Taxes | (6,388) | (6,988) | (6,624) | (4,157) | | Interest Expense |
-
| 302 |
-
|
-
| | Income Before Tax | (6,388) | (7,290) | (6,624) | (4,157) | | Income Tax Expense | (918) | 106 | 164 | 183 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,470) | (7,396) | (6,788) | (4,340) | | | Non-recurring Events | | Discontinued Operations | (298) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,768) | (7,396) | (6,788) | (4,340) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,768) | ($7,396) | ($6,788) | ($4,340) |
|
0.01% Nasdaq 
Income Statement
